Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOVER HEALTH INVESTMENTS, CORP. /DECLOV · Entity 4419 | Chief Growth Officer | September 16, 2022 | September 20, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOVER HEALTH INVESTMENTS, CORP. /DE
Report date September 16, 2022 · Filed September 20, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 872,821 |
Reported balance
After 2022-09-16 transaction · row 1
1 source rowRow 1 · 2022-09-16 · Grant · Acquired 353,356 · Balance 872,821 F1: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of September 16, 2022, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of September 16, 2022, in each case subject to the continued service of the Reporting Person on each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of September 16, 2022, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of September 16, 2022, in each case subject to the continued service of the Reporting Person on each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 16, 2022 Filed Sep 20, 2022 16:36 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 353,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-025242 · wf-form4_166370616282676.xml · nonDerivative · entry 1 Singh Prabhdeep · CIK 0001870027 · Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 872,821 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of September 16, 2022, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of September 16, 2022, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 18:19 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 255,474 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-006433 · wf-form4_164746913247003.xml · nonDerivative · entry 1 Singh Prabhdeep · CIK 0001870027 · Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519,465 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of March 14, 2022, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of March 14, 2022, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| July 08, 2021 Filed Jul 12, 2021 19:09 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 52,798 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046356 · doc4.xml · nonDerivative · entry 2 Singh Prabhdeep · CIK 0001870027 · Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,991 F2 · shares: Represents shares of Class A common stock underlying RSUs. The RSUs will vest in full on July 6, 2022, subject to the continuous service of the Reporting Person on such vesting date. Read SEC document |
| July 08, 2021 Filed Jul 12, 2021 19:09 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 211,193 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046356 · doc4.xml · nonDerivative · entry 1 Singh Prabhdeep · CIK 0001870027 · Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,193 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in equal annual installments over four years, beginning on July 6, 2022, subject to the continuous service of the Reporting Person on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.